A non-muscle myosin heavy chain 9 genetic variant is associated with graft failure following kidney transplantation

Background Despite current matching efforts to identify optimal donor-recipient pairs for kidney transplantation, alloimmunity remains a major source of late transplant failure. Additional genetic parameters in donor-recipient matching could help improve long-term outcomes. Here, we studied the impa...

Full description

Bibliographic Details
Main Authors: Felix Poppelaars, Siawosh K. Eskandari, Jeffrey Damman, Marc A. Seelen, Bernardo Faria, Mariana Gaya da Costa
Format: Article
Language:English
Published: The Korean Society of Nephrology 2023-05-01
Series:Kidney Research and Clinical Practice
Subjects:
Online Access:http://www.krcp-ksn.org/upload/pdf/j-krcp-22-061.pdf
_version_ 1797692890558758912
author Felix Poppelaars
Siawosh K. Eskandari
Jeffrey Damman
Marc A. Seelen
Bernardo Faria
Mariana Gaya da Costa
author_facet Felix Poppelaars
Siawosh K. Eskandari
Jeffrey Damman
Marc A. Seelen
Bernardo Faria
Mariana Gaya da Costa
author_sort Felix Poppelaars
collection DOAJ
description Background Despite current matching efforts to identify optimal donor-recipient pairs for kidney transplantation, alloimmunity remains a major source of late transplant failure. Additional genetic parameters in donor-recipient matching could help improve long-term outcomes. Here, we studied the impact of a non-muscle myosin heavy chain 9 gene (MYH9) polymorphism on allograft failure. Methods We conducted an observational cohort study, analyzing the DNA of 1,271 kidney donor-recipient transplant pairs from a single academic hospital for the MYH9 rs11089788 C>A polymorphism. The associations of the MYH9 genotype with risk of graft failure, biopsy-proven acute rejection (BPAR), and delayed graft function (DGF) were estimated. Results A trend was seen in the association between the MYH9 polymorphism in the recipient and graft failure (recessive model, p = 0.056), but not for the MYH9 polymorphism in the donor. The AA-genotype MYH9 polymorphism in recipients was associated with higher risk of DGF (p = 0.03) and BPAR (p = 0.021), although significance was lost after adjusting for covariates (p = 0.15 and p = 0.10, respectively). The combined presence of the MYH9 polymorphism in donor-recipient pairs was associated with poor long-term kidney allograft survival (p = 0.04), in which recipients with an AA genotype receiving a graft with an AA genotype had the worst outcomes. After adjustment, this combined genotype remained significantly associated with 15-year death-censored kidney graft survival (hazard ratio, 1.68; 95% confidence interval, 1.05–2.70; p = 0.03). Conclusion Our results reveal that recipients with an AA-genotype MYH9 polymorphism receiving a donor kidney with an AA genotype have significantly elevated risk of graft failure after kidney transplantation.
first_indexed 2024-03-12T02:34:06Z
format Article
id doaj.art-b5072a1c6613454688746a46e0a30fa4
institution Directory Open Access Journal
issn 2211-9132
2211-9140
language English
last_indexed 2024-03-12T02:34:06Z
publishDate 2023-05-01
publisher The Korean Society of Nephrology
record_format Article
series Kidney Research and Clinical Practice
spelling doaj.art-b5072a1c6613454688746a46e0a30fa42023-09-05T01:23:54ZengThe Korean Society of NephrologyKidney Research and Clinical Practice2211-91322211-91402023-05-0142338940210.23876/j.krcp.22.0616223A non-muscle myosin heavy chain 9 genetic variant is associated with graft failure following kidney transplantationFelix Poppelaars0Siawosh K. Eskandari1Jeffrey Damman2Marc A. Seelen3Bernardo Faria4Mariana Gaya da Costa5 Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsBackground Despite current matching efforts to identify optimal donor-recipient pairs for kidney transplantation, alloimmunity remains a major source of late transplant failure. Additional genetic parameters in donor-recipient matching could help improve long-term outcomes. Here, we studied the impact of a non-muscle myosin heavy chain 9 gene (MYH9) polymorphism on allograft failure. Methods We conducted an observational cohort study, analyzing the DNA of 1,271 kidney donor-recipient transplant pairs from a single academic hospital for the MYH9 rs11089788 C>A polymorphism. The associations of the MYH9 genotype with risk of graft failure, biopsy-proven acute rejection (BPAR), and delayed graft function (DGF) were estimated. Results A trend was seen in the association between the MYH9 polymorphism in the recipient and graft failure (recessive model, p = 0.056), but not for the MYH9 polymorphism in the donor. The AA-genotype MYH9 polymorphism in recipients was associated with higher risk of DGF (p = 0.03) and BPAR (p = 0.021), although significance was lost after adjusting for covariates (p = 0.15 and p = 0.10, respectively). The combined presence of the MYH9 polymorphism in donor-recipient pairs was associated with poor long-term kidney allograft survival (p = 0.04), in which recipients with an AA genotype receiving a graft with an AA genotype had the worst outcomes. After adjustment, this combined genotype remained significantly associated with 15-year death-censored kidney graft survival (hazard ratio, 1.68; 95% confidence interval, 1.05–2.70; p = 0.03). Conclusion Our results reveal that recipients with an AA-genotype MYH9 polymorphism receiving a donor kidney with an AA genotype have significantly elevated risk of graft failure after kidney transplantation.http://www.krcp-ksn.org/upload/pdf/j-krcp-22-061.pdfgeneticskidney transplantationmolecular motor proteinsnephrology
spellingShingle Felix Poppelaars
Siawosh K. Eskandari
Jeffrey Damman
Marc A. Seelen
Bernardo Faria
Mariana Gaya da Costa
A non-muscle myosin heavy chain 9 genetic variant is associated with graft failure following kidney transplantation
Kidney Research and Clinical Practice
genetics
kidney transplantation
molecular motor proteins
nephrology
title A non-muscle myosin heavy chain 9 genetic variant is associated with graft failure following kidney transplantation
title_full A non-muscle myosin heavy chain 9 genetic variant is associated with graft failure following kidney transplantation
title_fullStr A non-muscle myosin heavy chain 9 genetic variant is associated with graft failure following kidney transplantation
title_full_unstemmed A non-muscle myosin heavy chain 9 genetic variant is associated with graft failure following kidney transplantation
title_short A non-muscle myosin heavy chain 9 genetic variant is associated with graft failure following kidney transplantation
title_sort non muscle myosin heavy chain 9 genetic variant is associated with graft failure following kidney transplantation
topic genetics
kidney transplantation
molecular motor proteins
nephrology
url http://www.krcp-ksn.org/upload/pdf/j-krcp-22-061.pdf
work_keys_str_mv AT felixpoppelaars anonmusclemyosinheavychain9geneticvariantisassociatedwithgraftfailurefollowingkidneytransplantation
AT siawoshkeskandari anonmusclemyosinheavychain9geneticvariantisassociatedwithgraftfailurefollowingkidneytransplantation
AT jeffreydamman anonmusclemyosinheavychain9geneticvariantisassociatedwithgraftfailurefollowingkidneytransplantation
AT marcaseelen anonmusclemyosinheavychain9geneticvariantisassociatedwithgraftfailurefollowingkidneytransplantation
AT bernardofaria anonmusclemyosinheavychain9geneticvariantisassociatedwithgraftfailurefollowingkidneytransplantation
AT marianagayadacosta anonmusclemyosinheavychain9geneticvariantisassociatedwithgraftfailurefollowingkidneytransplantation
AT felixpoppelaars nonmusclemyosinheavychain9geneticvariantisassociatedwithgraftfailurefollowingkidneytransplantation
AT siawoshkeskandari nonmusclemyosinheavychain9geneticvariantisassociatedwithgraftfailurefollowingkidneytransplantation
AT jeffreydamman nonmusclemyosinheavychain9geneticvariantisassociatedwithgraftfailurefollowingkidneytransplantation
AT marcaseelen nonmusclemyosinheavychain9geneticvariantisassociatedwithgraftfailurefollowingkidneytransplantation
AT bernardofaria nonmusclemyosinheavychain9geneticvariantisassociatedwithgraftfailurefollowingkidneytransplantation
AT marianagayadacosta nonmusclemyosinheavychain9geneticvariantisassociatedwithgraftfailurefollowingkidneytransplantation